Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2003 Mar;60(3):629–638. doi: 10.1007/s000180300054

CD4+ T cell-mediated immunity against prion proteins

L Stoltze 1, H Rezaei 2, G Jung 4, J Grosclaude 3, P Debey 2, H Schild 1, H-G Rammensee 1
PMCID: PMC11138912  PMID: 12737322

Abstract:

The prion protein (PrPC) is essential for susceptibility to transmissible spongiform encephalopathies. A specific conformer of this protein (PrPSc) is, according to the 'protein only' hypothesis, the principal or only component of the infectious agent, designated prion. Transmission of prions between species is often inefficient, resulting in low attack rates and/or prolonged incubation times and is ascribed to a 'species barrier' caused by differences in the amino acid sequence of PrP between recipient and donor. In this report, we demonstrate that these differences in amino acid sequence result in presentation of distinct peptides on major histocompatibility complex class II molecules. These peptides result in activation of specific CD4+ T cells which leads to the induction of an effective immune response against foreign PrP as demonstrated by antibody production. Therefore, CD4+ T cells represent a crucial component of the immune system to distinguish between foreign and self PrP.

Keywords: Key words: T lymphocyte; prion protein; MHC class II.

Footnotes

Received 5 December 2002; received after revision 16 January 2003; accepted 5 February 2003

RID="*"

RID="**"

ID="*"Corresponding author.

ID="**"Present address: MRC Prion Unit, Institute of Neurology University of London, Queen Square London, WC1N 3BG (United Kingdom), Fax +44 20 7676 2180, e-mail: l.stoltze@prion.ucl.ac.uk


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES